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ABSTRACT Procaine amide azide, a derivative of the local
anesthetic procaine amide, was prepared and its interactions
with acetylcholine receptor-rich membrane fragments from
Torpedo californica electroplax were studied. Procaine amide
azide was radiolabeled by a method that may be of general use
for the preparation of other radioactive tertiary amines. When
low concentrations of 3H-labeled procaine amide azide were
photolyzed in the presence of receptor-rich membrane prepa-
rations, a simple pattern of incorrated radioactivity was seen
after electrophoresis on sodium dodecyl sulfate/polyacrylamide
gels. Only two major labeled bands were seen, corresponding
to apparent M, of about 43,000 and 90,000. When the length of
the gels was increased, the labeled band of lower Mr was re-
solved into two labeled proteins, one major and one minor, with
apparent M, of 43,000 and 40,000, respectively. The radioac-
tivity incorporated into the protein of M, 40,000 could be at-
tributed to interaction of [3H]procaine amide azide with cho-
linergic ligand-binding sites, whereas labeling of the polypep-
tide of M, 43,000 appears to represent interaction of the pho-
tolabile derivative with another class of sites. The labeling
component of 90,000 Mr could be removed by preparation of
membrane fragments in iodoacetamide-containing buffer and
therefore appeared unrelated to the acetylcholine receptor.
Membrane fragments with high concentrations of nicotinic
acetylcholine receptor (AcChoR) have been isolated from the
electric tissue of several electric rays (1-3) and the electric eel
Electrophorus (4). The in vitro characterization of these systems
has focused largely on the ligand-binding properties of the
AcChoR recognition site. These ligands may be classified as (i)
acetylcholine (AcCho) and compounds of similar pharmaco-
logical action (agonists), (ii) compounds that inhibit depolar-
ization (antagonists; e.g., d-tubocurare), and (iii) a-bungaro-
toxin (a-BuTx) and related snake neurotoxins that specifically
and irreversibly block AcCho response in vivo (5, 6) by binding
to the AcChoR. The effects in vivo of several compounds whose
primary site of interaction is distinct from the AcCho recog-
nition site suggest that they may be useful probes for the
membrane component or components related to ion translo-
cation. One such compound is the alkaloid histrionicotoxin
(HTX), first isolated by Daly et al. (7). In vitro studies have
shown that membrane fragments from Torpedo californica
bind 3H-labeled H12-HTX in a specific manner with a Kd of
0.3-0.5 ,M and a stoichiometry of 1 HTX site to 4 a-BuTx sites
(8) in addition to a large nonspecific binding component.
Caeruleotoxin was considered as another candidate for a spe-
cific probe of the "ionic conductance modulator" (9). However,
postsynaptic inhibition by this polypeptide has been attributed
to its phospholipase activity (10). Local anesthetics comprise
another class of potentially useful compounds for study of
mechanisms related to ion channel function.
At the neuromuscular junction, local anesthetics alter the
normal time course of end-plate currents induced by AcCho;
whereas normal end-plate currents decay with a single expo-
nential time course, the decay becomes multiphasic in the
presence of procaine and other local anesthetics (11-15). Recent
studies (16-18) have led to proposals that this action might be
explained by binding of a local anesthetic to the open channel
(i.e., conducting) form of the receptor, resulting in a decreased
ionic conductance. These compounds, then, might be used as
probes for the structure(s) involved in translocation of ions across
the postsynaptic membrane and its relationship to (or identity
with) the AcChoR.
The interactions of various local anesthetics with receptor-
rich membrane fragments have been studied by means of in-
hibition of a-toxin binding (19, 20) and by extrinsic fluorescent
probes (21-23). In the studies reported here, we prepared an
azido analog of the local anesthetic procaine amide (I); namely,
procaine amide azide (PAA) (II). This compound was chosen
over the procaine derivative (24) because the amide bond is less
susceptible to hydrolysis than is procaine's ester linkage. We
have previously shown that the membranes contain polypep-
tides of Mr 40,000, 50,000, 60,000, and 65,000 (2, 3) in addition
to other major species of Mr ;43,000 and 90,000 (25). Photolysis
of [3H]II in the presence of AcChoR-rich membrane fragments
was coupled with sodium dodecyl sulfate (NaDodSO4)/poly-
acrylamide gel electrophoresis to demonstrate which poly-
peptides of the membrane fragment preparation were involved
in local anesthetic binding.
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MATERIALS AND METHODS
Preparation of AcChoR Membrane. Fragments. T. cali-
fornica were obtained locally. After they were killed, the
electric organs were excised, frozen in liquid nitrogen, and then
stored at -90'C until use. AcChoR-enriched membrane
fragments were prepared as described (2, 3) or by a modifica-
tion of these methods. In the latter case, centrifugation on a
discontinuous sucrose gradient in a Beckman VTi-50 reorienting
tube rotor replaced the zonal centrifugation step. In this way
the gradient centrifugation time was reduced from overnight
to about 1 hr. Specific activities were comparable to those ob-
tained by zonal centrifugation (unpublished data). When
Abbreviations: AcCho, acetylcholine; AcChoR, acetylcholine receptor;
a-BuTx, a-bungarotoxin; PAA, procaine amide azide; Carb, car-
bamylcholine; HTX, histrionicotoxin; NaDodSO4, sodium dodecyl
sulfate.
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membrane fragments were treated with iodoacetamide, it was
added during homogenization to a concentration of 1 mg/ml
of homogenate. The buffer in subsequent steps of the purifi-
cation did not contain iodoacetamide. The concentration of
a-BuTx binding sites was measured by the method of Schmidt
and Raftery (26); protein was measured by the method of
Lowry et al. (27).
Synthesis and Characterization of PAA. Unlabeled PAA
was synthesized from procaine amide-hydrochloride (Pfaltz
and Bauer, Inc., Stamford, CT) by preparation of the corre-
sponding diazonium salt followed by its reaction with sodium
azide. The identity of the product was confirmed by elemental
analysis. Calculated for C13H2ON5ClO: C, 52.4; H, 6.77; N, 23.5;
Cl, 11.9. Found: C, 52.6; H, 6.8; N, 23.4; Cl, 12.2. The synthesis
of [3H]PAA is outlined in Fig. 1. The interactions of PAA with
membrane-bound AcChoR were characterized in several ways.
The apparent inhibition constant of PAA towards a-BuTx
binding was determined by inhibition of the initial rate of
'25I-labeled a-BuTx binding caused by varying concentrations
of the ligand. For details, see the legend of Fig. 2A. The rate
of the transition of the receptor from low to high affinity caused
by 1 ,gM carbamylcholine (Carb) in the presence and absence
of PAA was measured by the method of Lee et al. (30). The
effects of PAA on the fluorescence of membrane-bound ethi-
dium bromide (Calbiochem) were measured as described
(22).
Labeling and Polyacrylamide Gel Electrophoresis.
Membrane fragments were incubated with the desired con-
centration of [3H]PAA in the dark for 20-30 min at 0C. The
solutions were irradiated for 2 min in a quartz cuvette (with
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FIG. 1. Synthesis of [3H]PAA. [3H]Ethyl tosylate ([3H]-
CH3CH2OTs) was prepared from [1-[3H](N)]ethanol (93.6 Ci/mol,
New England Nuclear) and tosyl chloride in dry pyridine (28). Sodium
thiophenoxide was prepared by a modification of the method of
Jenden and Hanin (29). In the dequaternization step, there was a
2/3rd probability that a radioactive ethyl group would not be removed.
The expected specific activity of the final product was therefore 2/3rd
that of the ethyl tosylate or 62.4 Ci/mol. After purification on a silica
gel column, the concentration of the [3H]PAA stock solution was
calculated from its absorbance at 270 nm, with unlabeled PAA as
standard. The specific activity was determined by liquid scintillation
counting of aliquots of the stock solution and found to be 54 Ci/mol
±
-10%, in agreement with the predicted value.
constant stirring) by using a UVSL-25 lamp (Ultraviolet Prod-
ucts, San Gabriel, CA) on the short-wavelength setting. The
membranes were centrifuged for 15 min in an Eppendorf
model 3200 centrifuge, and the supernatant was discarded. The
pellet was resuspended in 1 ml of Torpedo Ringer's solution and
the membranes were repelleted as above. After the supernatant
was discarded, the pellets were dissolved in sample buffer [10%
(wt/vol) glycerol/3% (wt/vol) NaDodSO4/100 mM di-
thiothreitol/62.5 mM Tris-HCI, pH 6.8] and denatured by
heating at 1000C for 2 min. NaDodSO4/polyacrylamide gel
electrophoresis was carried out in the system of Laemmli (31).
Gels were either 1 X 10cm or, when it was desired to distinguish
between label on the 40,000 and 43,000 Mr bands, 1 X 20 cm.
In both cases the separating gels were 8.75% (wt/vol) in acryl-
amide.
After electrophoresis the gels were either sliced immediately
or after staining in 10% HOAc/25% MeOH/0.05% Coomassie
Brilliant Blue and destaining in the same solution without the
dye. Gels were sliced with a Hoeffer Scientific Instruments
SL-280 gel slicer. Each slice was placed in a scintillation vial
with 0.5 ml of 30% H202; the vials were tightly capped and
heated at 70'C for 5 hr. After cooling and addition of scintil-
lation fluid, the radioactivity in the vials was determined by
using the tritium channel of a Packard 3375 liquid scintillation
counter. For the 20-cm gels, radioactivity was measured in only
that portion of the gel containing the 40,000-90,000 Mr bands
because initial experiments showed no significant incorporation
of radioactivity outside of this Mr region.
RESULTS
PAA only weakly inhibited 125I-labeled a-BuTx binding to
membrane-bound AcChoR but was slightly more effective than
its parent compound in this respect (Fig. 2A). Titration of
membrane fragments with PAA by using the fluorescent probe
ethidium (Fig. 2B) showed the same qualitative effects as seen
with the local anesthetic procaine (22). When the data were
corrected for nonspecific (i.e., not displaceable by a-BuTx)
effects, a fluorescence increase was observed in the micromolar
range, whereas addition of millimolar concentrations of PAA
caused a decrease in the signal (Fig. 2B).
Since there was evidence for PAA binding to some site with
an affinity higher than that measured by 125I-labeled a-BuTx
inhibition (i.e., the fluorescence enhancement, Fig. 2B) and
since local anesthetics have been reported to increase the rate
of the Carb-induced transition in receptor affinity at concen-
trations below those that directly inhibit a-BuTx binding (20,
32), the effects of PAA on the rate of this process were exam-
ined. Up to concentrations of 50 ,uM PAA, the rate of the tran-
sition of the receptor from low to high affinity caused by 1 ,uM
Carb (30) was only slightly changed. The half-time of 97 ± 23
sec (SD) for this process in the presence of 1 ,uM Carb alone was
reduced to only 71 ± 16 sec at the highest concentration of PAA
tested, a 1.4 + 0.4-fold decrease.
Fig. 3A shows a NaDodSO4 gel electrophoresis profile of
membrane fragments that were photolabeled with [3H]PAA.
Only two labeled bands were seen. Although the relative mo-
bility of the faster migrating band corresponded to a Mr Of
about 42,000-44,000, the limited resolution of the gels in this
region made it impossible to determine if the Mr 40,000 re-
ceptor band also contained bound label. The amount of radio-
activity incorporated in the Mr 90,000 band varied from
preparation to preparation, as did the intensity of its Coomassie
Brilliant Blue staining. When membrane fragments homoge-
nized in the presence of iodoacetamide were labeled under the
same conditions, almost no radioactivity was incorporated into
the Mr 90,000 band (Fig. 3B). The decrease in the intensity of
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FIG. 2. (A) Inhibition of initial rate of 1251-labeled a-BuTx
binding as a function of ligand concentration. Membrane fragments
63 nM in toxin-binding sites were incubated with the indicated con-
centration of ligand for 20 min and 470 nM 1251-labeled a-BuTx was
added to start the reaction. The initial rates, as determined from
semilogarithmic plots of the data, were fit to a linearized form of the
empirical relation kob8 = k/(1 + L/Ki), in which kobs was the initial
rate in the presence of ligand concentration L, k the rate in the ab-
sence of ligand, and Ki the apparent inhibition constant. The line
represents calculated Ki values of 0.95 ± 0.06 mM for PAA (0) and
1.7 ± 0.1 (SD) mM for procaine amide (0). (B) Effects of PAA on
fluorescence of membrane-bound ethidium. Concentrations of a-
BuTx binding sites and of ethidium were both 1 MM. AFcorrected is the
change in ethidium fluorescence from the initial level at [PAA] = 0
for membrane fragments alone minus the corresponding change for
membrane fragments that were incubated with an excess of a-
BuTx.
the Coomassie Blue staining was less dramatic. Two possibilities
could explain the changed labeling pattern in iodoacetamide-
treated membrane fragments: (i) the component of Mr 90,000
labeled by PAA was lost during the purification process, pre-
sumably because artifactual disulfide bonds could not form or
(ii) iodoacetamide altered the binding properties of the mem-
brane fragments for PAA and this change was reflected in the
labeling of the Mr 90,000 band. Because this band was labeled
when membranes were treated with iodoacetamide after
preparation (not shown), the second possibility could be ruled
out. In accord with the conclusion that iodoacetamide treatment
did not perturb the interactions of PAA with membrane frag-
ments, the ethidium fluorescence signal, when membranes were
titrated with PAA, was unchanged. Both the increased fluo-
rescence at low concentrations and the decrease in signal at
higher ones were observed.
When membranes were run on gels 20 cm long, the separa-
tion between the 40,000 and 43,000 Mr bands was increased.
As Fig. 4 shows, both bands were labeled, with the majority of
the radioactivity in the higher Mr band. Photolysis of mem-
brane fragment solutions containing both [3H]PAA and 2-5 IiM
Carb resulted in decreased incorporation of radioactivity into
the 40,000 Mr but not the 43,000 Mr band (or the residual
90,000 Mr label, not shown). The Mr 40,000 subunit of T. cal-
ifornica contains sites for binding of a-toxins (33, 34) and
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FIG. 3. Polyacrylamide gel electrophoresis profiles of AcChoR-
enriched membrane fragments labeled with [3H]PAA. (A) Solution
0.5 ,tM in 125I-labeled a-BuTx binding sites and 5 AM in [3H]PAA was
treated as described in Materials and Methods. A total of 0.75 nmol
of 1251-labeled a-BuTx binding sites was placed on the gel. (B) Con-
centrations were the same as A except that the membrane fragments
were homogenized in the presence of iodoacetamide. One nanomole
of 1251-labeled a-BuTx sites was placed on the gel. Gel slice 1 is the
position of the tracking dye; the last slice is the top of the gel.
cholinergic ligands, such as the antagonists 4-(N-maleimido)-
benzyltrimethylammonium iodide (35) and bis-3-aminopyri-
dinium-l-azide (25) and the agonist bromacetylcholine (un-
published data). The label incorporated into the polypeptide
of Mr 40,000 was therefore attributed to PAA binding at these
site(s). The small amount of bound radioactivity was probably
a reflection of the low affinity (determined by inhibition of
'25I-labeled a-BuTx binding) of these site(s) for the anesthetic
analog.
DISCUSSION
The-postsynaptic membrane responds to cholinergic agonists
in vivo by a transient increase in cation permeability, and this
response may be directly inhibited by compounds that block
the binding of agonists. The snake neurotoxin a-BuTx, whose
blockage is irreversible (5, 6), is especially useful in this respect.
The response to agonists may also be indirectly blocked by
conversion of the AcChoR-ion translocation complex to an
inactive conformation (desensitization) or by perturbation of
the structure(s) involved in ion translocation or of its coupling
to the AcChoR. Membrane fragments from Torpedo electro-
plax exhibit a number of properties in vitro consistent with in
vivo observations at the neuromuscular junction and therefore
constitute a good system for the study of postsynaptic function:
(i) these membranes bind agonists and antagonists, and this
binding is irreversibly blocked upon addition of a-BuTx; (ii)
Carb induces increased ion flux from Torpedo membrane
fragments in vitro, as measured by release of 22Na+, and this
release is inhibited by both a-BuTx (36-38) and by HTX, a
noncompetitive inhibitor (unpublished data); and (iii) in ad-
dition, exposure to cholinergic agonists causes a reversible in-
crease in the AcChoR's ligand affinity (20, 30, 39-41), a process
that may be an in vitro correlate to the in vivo phenomenon of
desensitization. Tertiary amine local anesthetics have been
reported to affect the rate of both the in vivo process of densi-
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FIG. 4. Improved separation of membrane components on 1 X
20 cm NaDodSO4/polyacrylamide gels. (A) Scan of Coomassie Bril-
liant Blue staining intensity. The central portion of a 1 X 20 cm gel
was scanned with a Gilford Linear transport accessory with a specially
made cuvette and holder. Note that the region around Mr 43,000
contained several staining bands that were not well resolved. The
relative amounts of each polypeptide present could not be quantitated
due to the very high absorbance and the fact that the stain did not
always penetrate to the center of the gels because of their large di-
ameter. (B) Radioactivity profile. A total of 2 nmol of 125I-labeled
a-BuTx sites was placed on the gel. The labeling conditions were
identical to those in Fig. 3B. The major amount of radioactivity was
incorporated at a position corresponding to aMr of 43,000 with minor
incorporation at Mr 40,000 and 90,000. Each gel slice was 1.1 mm long,
with a total of 152 slices from the dye front to the top of the gel.
tization (42, 43) and the in vitro affinity change (refs. 20 and
32; unpublished data). In vivo, local anesthetics also interfere
with the mechanism of ion translocation (11-18).
Since incorporation of [3H]PAA into the protein of Mr 40,000
was prevented by the presence of Carb, the labeling seen on this
polypeptide could be interpreted as being due to PAA bound
at cholinergic ligand-binding sites. The identity of the labeled
band of Mr 43,000 was less clear. Sobel et al. (44) have recently
reported isolation of a particulate protein fraction of this mo-
lecular weight from T. marmorata membrane fragments.
These authors observed that the fluorescence of quinacrine
associated with this 43,000 Mr protein was decreased upon
addition of HTX in a manner similar to the effects of HTX on
quinacrine fluorescence in preparations of intact membrane
fragments. It was not possible, however, to equate the protein
of Sobel et al. with the band of Mr 43,000 labeled by [3H]PAA
because the Coomassie Blue staining intensity of high resolution
(20 cm) gels of T. californica membrane fragments indicated
the presence of more than one protein with approximately this
molecular weight (Fig. 4). Because of limitations in the reso-
lution of these gels, we could not unambiguously determine
which partially resolved component was labeled by [3H]PAA.
In addition, preliminary results showed that the presence of
micromolar concentration of HTX did not decrease the amount
of radioactivity incorporated in the 43,000 Mr band when T.
californica membranes were photolyzed in the presence of
[3H]PAA. Conversely, unlabeled PAA displaced membrane-
bound 3H-labeled H12-HTX with an apparent Ki of 500 ,uM
(unpublished data), a concentration 2 orders of magnitude
higher then that necessary to label membrane fragments with
[3H]PAA and, as shown in Fig. 2B, well above those concen-
trations that enhance the fluorescence of membrane-bound
ethidium bromide. Thus, although HTX and local anesthetics
show similar actions both in vi'vo and in vitro, they may bind
to separate sites on the same or on different polypeptide
chains.
The amount of radioactivity incorporated into the protein
of Mr 90,000 varied from one preparation to another. The
possibility that this band was due to disulfide bonds between
smaller labeled bands was ruled out because dithiothreitol was
included in the sample buffer for all NaDodSO4/polyacryl-
amide gel electrophoresis experiments. The replacement of
dithiothreitol with mercaptoethanol also had no effect. Because
the 90,000 Mr labeling band was easily separable from mem-
brane fragments by homogenization in the presence of iodo-
acetamide, it was tentatively assumed to be unrelated to the
AcChoR-ion translocation complex. Although we could not rule
out that the 90,000 Mr protein might play a role in ion trans-
location, it is of interest that iodoacetamide treatment did not
alter any measured properties in vitro of the membrane frag-
ments, except for the [3H]PAA labeling pattern. The association
rate constant for a-BuTx binding was unchanged; the mem-
branes underwent the change from low to high affinity caused
by Carb and bound HTX in a specific manner (unpublished
data). In addition, iodoacetamide-treated membranes still
showed agonist-mediated cation flux (unpublished data).
Therefore, the assumption that the 90,000 Mr protein was not
directly related to the AcChoR complex seemed justified.
Although the data presented here have demonstrated that
the local anesthetic analog PAA binds to several components
in T. californica membrane fragments, the roles these com-
ponents play in in vivo or in vitro processes, such as channel
blockage of desensitization, are not understood.
The precise mechanisms by which the local anesthetic effects
of procaine or procainamide are exerted are not yet resolved.
With respect to the possible in vitro correlate of densensitiza-
tion, namely, the conversion of the membrane-bound receptor
from a state(s) of low to high affinity by Carb, PAA decreased
the half-time of this transition by a factor of only 1.4 ± 0.4 at
a concentration 10 times above that used in the labeling ex-
periments. The precision of our assay did not allow us to decide
if this represented a significant change in the rate of this tran-
sition; however, this finding was not at variance with observa-
tions for other local anesthetics such as procaine, since we have
observed that the effects on this rate differ both qualitatively
and quantitatively for different anesthetics (unpublished ob-
servations). Therefore, little or no effect on the rate of this re-
ceptor transition at a given concentration of local anesthetic
could indicate that either little or no local anesthetic was bound
to the site(s), affecting the rate of conversion, or the compound
was bound to the site(s), but did not affect the rate to an ap-
preciable extent. Compounds such as some local anesthetics (20,
32), detergents (32, 45), caeruleotoxin (9, 10), and, in some
tissues (46) but not others (8), HTX affect the rate of transition
of receptor from a state of low to high affinity. However, de-
spite the variety of effects observed for these compounds, the
mechanisms by which they exert the effect are poorly under-
stood.
At the present time there are few specific probes useful for
identification of the site(s) to which compounds such as HTX
or local anesthetics bind to the postsynaptic membrane and
t-- I I
---I
Proc. Natl. Acad. Sci. USA 76 (1979)
-A
Proc. Natl. Acad. Sc. USA 76 (1979) 85
exert their physiological effects. PAA holds promise for eluci-
dation of some of the mechanisms involved.
Note Added in Proof. After submission of this manuscript we found
that Levy et al. (47) have used a similar approach by using p-azido-
benzoyldiethylaminoethanol in studies of hepatocyte plasma mem-
branes.
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